動脈粥樣硬化
動脈粥樣硬化（Atherosclerosis）是一種在動脈壁形成纖維脂肪性病變的疾病，在世界範圍內引起許多發病率和死亡率，包括大多數心肌梗死和許多中風，以及致殘性外周動脈疾病。動脈粥樣硬化病變的發展可能需要低密度脂蛋白，一種攜帶膽固醇通過血液的微粒。動脈粥樣硬化及其血栓併發症的其他危險因素包括高血壓、吸烟和糖尿病。越來越多的證據也表明免疫系統的作用，因為新出現的危險因素包括炎症和尅隆性造血。動脈粥樣硬化形成的細胞和分子生物學的研究已經提供了相當多的洞察機制，將所有這些危險因素與動脈粥樣硬化的發展和這種疾病的臨床表現聯系起來。
動脈粥樣硬化的部份研究:
- 心血管健康（1）動脈暢通（4）血栓（3,5）血壓（4）膽固醇（5）血小板（6）甘油三脂（4）神經保護（4）血壓、膽固醇；7,8
- 全身血管、動脈彈性7,8,9,10動脈氧化（11）血小板及血栓（12,13）動脈彈性（14）、膽固醇及甘油三酯水準（15,16）、
- 微循環脂質氧化（17,18）、斑塊消化（19,20）正常血液回圈（21）、鈣化心臟及主動脈（22,23）
AtherosclerosisAtherosclerosis, the formation of fibrofatty lesions in the artery wall, causes much morbidity and mortality worldwide, including most myocardial infarctions and many strokes, as well as disabling peripheral artery disease. Development of atherosclerotic lesions probably requires low-density lipoprotein, a particle that carries cholesterol through the blood. Other risk factors for atherosclerosis and its thrombotic complications include hypertension, cigarette smoking and diabetes mellitus. Increasing evidence also points to a role of the immune system, as emerging risk factors include inflammation and clonal haematopoiesis. Studies of the cell and molecular biology of atherogenesis have provided considerable insight into the mechanisms that link all these risk factors to atheroma development and the clinical manifestations of this disease.
Part of the study on atherosclerosis
- Cardiovascular health (1) arterial patency (4) thrombosis (3,5) blood pressure (4) cholesterol (5) platelet (6) triglyceride (4) neuroprotection (4) blood pressure and cholesterol; 7,8
- Systemic vascular and arterial elasticity 7,8,9,10 arterial oxidation (11) platelet and thrombus (12,13) arterial elasticity (14), cholesterol and triglyceride levels (15,16)
- Microcirculation lipid oxidation (17,18), plaque digestion (19,20), normal blood circulation (21), calcified heart and aorta (22,23)
Refs:
1.World Health Organization. Cardiovascular diseases. 2011, http://www.who.int/cardiovascular diseases/en/
2. Heinicke RM, van der Wal L, Yokoyama M. Effect of bromelain (Ananase) on human platelet aggregation. Experientia. 1972;28(10):844–845. [PubMed] [Google Scholar]
3.Secor ER, Jr., William FC, Michelle MC, et al. Bromelain exerts anti-inflammatory effects in an ovalbumin-induced murin model of allergic disease. Cellular Immunology. 2005;237:68–75. [PMC free article] [PubMed] [Google Scholar]
4.Hongjie Chen,1 Eileen M McGowan,2 Nina Ren,3 Sara Lal,2 Najah Nassif,2 Fatima Shad-Kaneez,2 Xianqin Qu,2 and Yiguang Lin2 Nattokinase: A Promising Alternative in Prevention and Treatment of Cardiovascular Diseases. Biomark Insights. 2018; 13: 1177271918785130. Published online 2018 Jul 5. doi: 10.1177/1177271918785130. PMCID: PMC6043915. PMID: 30013308
5.Kevin Yueju Wang, 1 ,* Lauren Tull, 1 Edwin Cooper, 2 Nan Wang, 3 and Dehu Liu 3 ,* Recombinant Protein Production of Earthworm Lumbrokinase for Potential Antithrombotic Application. Evid Based Complement Alternat Med. 2013; 2013: 783971. Published online 2013 Dec 12. doi: 10.1155/2013/783971. PMCID: PMC3876685. PMID: 24416067
6.King DE, Ellis TM, Everett CJ, Mainous AG. Medication use for diabetes, hypertension, and hypercholesterolemia from1988–1994 to 2001–2006. Southern Medical Journal. 2009;102(11):1127–1132.Chappell LT, Janson M. EDTA chelation therapy in the treatment of vascular disease. J Cardiovasc Nurs. 1996; 10:78-
7.Chappell LT, Janson M. EDTA chelation therapy in the treatment of vascular disease. J Cardiovasc Nurs. 1996; 10:78-86.
8. Olszewer E, Sabbag FC, Carter JP. A pilot double-blind study of sodium-magnesium EDTA in peripheral vascular disease. J Natl Med Assoc 1990; 82:173-174.
9. Anderson HC1, Mechanisms of pathologic calcification. Rheumatic Diseases Clinics of North America, 01 Aug 1988, 14(2):303-319. PMID: 2845491
10. Andrew L Durham, Mei Y Speer, Marta Scatena, Cecilia M Giachelli, Catherine M Shanahan Author Notes. Role of smooth muscle cells in vascular calcification: implications in atherosclerosis and arterial stiffness. Cardiovascular Research, Volume 114, Issue 4, 15 March 2018, Pages 590–600, https://doi.org/10.1093/cvr/cvy010. Published:05 March 2018
11.Rafieian-Kopaei, M., Setorki, M., Doudi, M., Baradaran, A. and Nasri, H. (2014). Int J Prev Med, 5(8), pp.927-46.
12. Shi, Y., Shi, Y., Yang, L., Li, X., Zhao, J., Qu, Y., Zhu, H., Wang, D., Cheng, R., Yang, C., Xu, M. and Zhang, Y. (2015). J Ethnopharmacol, 162, pp.87-96.
13. Wang, B., Hong, X., Li, L., Zhou, J. and Hao, X. (2000). Planta Medica, 66(6), pp.511-515.
14.Beulens, J., Bots, M., Atsma, F., Bartelink, M., Prokop, M., Geleijnse, J., Witteman, J., Grobbee, D. and van der Schouw, Y. (2009). Atherosclerosis, 203(2), pp.489-493.
15. Ganesan, B., Anandan, R. and Rajesh, R. (2008). International Journal of Biomedical and Pharmaceutical Sciences, 2(1), pp.65-69.
16. Küskü-Kiraz, Z., Genc, S., Bekpınar, S., Ünlücerci, Y., Çevik, A., Olgaç, V., Gürdöl, F. and Uysal, M. (2017). Nutrition, 45, pp.41-48.
17. Kasim, M., Kiat, A., Rohman, M., Hanifah, Y. and Kiat, H. (2009). The Journal of Alternative and Complementary Medicine, 15(5), pp.539-544.
18. Ji, H., Wang, L., Bi, H., Sun, L., Cai, B., Wang, Y., Zhao, J. and Du, Z. (2008). European Journal of Pharmacology, 590(1-3), pp.281-289.
19. Chanalia, P., Gandhi, D., Jodha, D. and Singh, J. (2011). Reviews in Medical Microbiology, 22(4), pp.96-101.
20.. UmaMaheswari, T., Hemalatha, T., Sankaranarayanan, P. and Puvanakrishnan, R. (2016). Indian J Exp Biol, 54(1), pp.7-16.
21. Peng, Y., Yang, X. and Zhang, Y. (2005). Applied Microbiology and Biotechnology, 69(2), pp.126-132.
22. Grases, F., Sanchis, P., Perello, J., Isern, B., Prieto, RM., Fernandez-Palomeque, C., Fiol, M., Bonnin, O., Torres, JJ. (2006). Frontiers in Bioscience, 11(1), p.136.
23. Akihiro Shimomura 1 , Isao Matsui 1 , Takayuki Hamano 2 , Takuya Ishimoto 3 , Yumiko Katou 4 , Kenji Takehana 5 , Kazunori Inoue 1 , Yasuo Kusunoki 1 , Daisuke Mori 1 , Chikako Nakano 1 , Yoshitsugu Obi 1 , Naohiko Fujii 6 , Yoshitsugu Takabatake 1 , Takayoshi Nakano 3 , Yoshiharu Tsubakihara 2 , Yoshitaka Isaka 7 , Hiromi Rakugi 1 .Dietary L-lysine prevents arterial calcification in adenine-induced uremic rats. J Am Soc Nephrol. 2014 Sep;25(9):1954-65. doi: 10.1681/ASN.2013090967. Epub 2014 Mar 20. PMID: 24652795.PMCID: PMC4147981 .
